Intra-Cellular Therapies (ITCI) – Analyst Ratings
-
Intra-Cellular Therapies (ITCI) PT Raised to $103 at Baird
-
Intra-Cellular Therapies (ITCI) PT Raised to $91 at BofA Securities
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ITCI Stock Lookup